Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
P-glycoprotein (P-gp) is a 170 kDa transmembrane glycoprotein that functions as an ATP-dependent efflux pump. It plays a crucial role in multidrug resistance and the transport of various substances across cell membranes. Structurally, it has two transmembrane domains and two nucleotide-binding domains that bind and hydrolyze ATP, connected by a flexible linker. Encoded by the MDR1 (ABCB1) gene, P-gp is widely distributed in tissues like the GI tract, blood-brain barrier, liver, and kidney, where it protects against xenobiotics, facilitates excretion, and restricts drug uptake into the brain. Its ability to transport a broad range of substrates with little specificity contributes significantly to multidrug resistance, drug bioavailability, and drug-drug interactions. P-gp's clinical significance is high, particularly in cancer resistance, pharmacokinetics, CNS drug delivery, and transplantation.
P-glycoprotein acts as an ATP-dependent efflux pump, actively transporting diverse substrates out of cells against concentration gradients using the energy from ATP hydrolysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P-glycoprotein (P-gp).